Novartis drops after cholesterol drug fails in late-stage trial Shares of Novartis dropped as much as 3.6% early Monday after it said an experimental drug failed to reduce the risk of cardiovascular e...
Traders work at the New York Stock Exchange on Aug. 25, 2026. NYSE Stocks rose on Wednesday as U.S. Treasury yields took a breather from the recent run-up that sent them to multiyear highs. The S&...